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Implicated Pathological functions of 
TE (e.g. HERVs; lINEs, and SINEs) 
(i) Cancer
It is being postulated that in 
somatic cells, the transposition of 
HERVs and other TEs may land into 
tumour suppressor genes and this 
could cause neoplastic transformation. 
It is a known fact that many cancers 
feature global DNA hypomethylation 
and localized hypermethylation of 
CpG islands of tumour suppressor 
genes.1 Since DNA methylation is one 
of the epigenetic mechanisms that cells 
have evolved to check on TEs from 
being unleashed and doing havoc in 
their genome, it is being postulated 
that with the event of global DNA 
hypomethylation, the TEs transpose 
because the epigenetic constraints are 
lifted. If some TEs end up in or near the 
promoter region of tumour suppressor 
genes, the chromatin structure is 
heterochromatized (i.e. become 
condensed and compacted) and hence 
silenced for transcription. With the 
function of tumour suppressor genes 
switched off, neoplastic transformation 
sets in. Generally, tumorigenesis 
occurs because the silenced tumour 
suppressor genes result in (i) altering the 
cell cycle, (ii) blocking apoptosis or (iii) 
blocking DNA repair. 1 Later on as the 
global DNA hypomethylation continues, 
genes inhibiting cell invasion and 
dissemination also get involved and are 
silenced by their promoter undergoing 
CpG island hypermethylation.2 
Examples of such genes (called 
metastasis suppressor genes) that 
get silenced and result in dissemination, 
often normally code for proteins that 
make cells ‘stick’ together but not only 
(Table 11). Thus when they get silenced, 
the tumour cells do not ‘stick’ in the 
original site but start to detach, invade 
and disseminate.
Other retroelements that have been 
found to cause cancer are LINE-1 
sequences, involving the myc gene in 
breast carcinoma and involving the APC 
(adenomatous polyposis carcinoma) 
gene in colon cancer.
 The HERV-K provirus family is 
implicated in several cancers. This 
is because members of this family 
have open reading frames (ORfs) 
for all their viral genes. An ORF is a 
DNA sequence without a stop codon 
in the given frame.  This translates 
that HERV-K are the most likely to 
be biologically active and potentially 
pathogenic because their sequences 
are most likely to be expressed.
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Genes ® Proteins Effect
laminin genes ➔ laminins
Laminins induce and maintain cell polarity; establish barriers between 
tissue compartments; organize cells into tissues; protect adherent cells 
from detachment-induced cell death.
TIMP genes ➔ Tissue inhibitors of 
proteinases (TIMPs)
TIMPs antagonize matrix metallo-proteinases (thus suppress tumour 
growth, angiogenesis, invasion and metastasis).
semaphorin genes ➔ semaphorins
Semaphorins are axon guidance proteins that block VEGF (vascular 
endothelial growth factor) autocrine activity.
Thrombospondins (THBS) genes ➔ 
thrombospondins
Thrombospondins are proteins that regulate tissue genesis and 
remodelling.
Cadherin genes (e.g. E-Cadherin, 
H-cadherin, R-cadherin) ➔ cadherins
Cahderins are a group of cell adhesion molecules that form stable cell-cell 
junctions.
Table 11:  Some examples of ‘Metastasis Suppressor Genes’ and the effects of their products
Cancer Implicated HERV
Breast cancer HERV-K
Ovarian cancer HERVs
Melanoma HERV-K
Myeloproliferative disease HERV-K
Testicular tumours (seminomas; 
teratomas)
HERV-K (sub-group HML-2)
Table 12: Putative association of HERVs in cancer
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(ii) Autoimmune Diseases
• Rheumatoid Arthritis (RA)
The expression of HERV-K18 
was up-regulated in patients with 
juvenile rheumatoid arthritis.3  The 
possible mechanism offered is that 
of a super-antigen (SAG) stimulation 
in auto-reactive T cells causing the 
autoimmunity.
• Systemic lupus Erythematosus 
(SlE)
Here it is being implicated that 
HERV-K env protein is the culprit 
causing autoimmunity through 
molecular mimicry and immuno-
modulation. Molecular mimicry refers 
to similar structures that molecules 
share between them despite arising 
from dissimilar origins. For example 
the molecules might share some linear 
amino acid sequences or their 3-D 
conformational fit, even though their 
origins are separate (e.g. a virus and a 
normal host self determinant). In SLE, 
it is being implied that the determinant 
shared by the host and the HERV-K env 
protein evokes an immune response 
and causes the destruction of cells and 
tissue.4 
• Insulin Dependent Diabetes 
Mellitus (IDDM)
The culprit here is a viral sequence 
appertaining to a HERV-K family.5   
Specifically, HERV-K env encodes a 
super-antigen which allegedly is being 
held responsible to play a part in the 
etiology of insulin-dependent diabetes 
mellitus (IDDM).
• Psoriasis
Moles J. P. et al.6   found 3 HERV 
families in psoriatic lesions, (HERV-W, 
HERV-K, and HERV-E). They proposed 
that the expressed sequences of these 
HERVs have roles in the development of 
psoriasis and are doing further research 
in this regard.
(iii) Neurological Diseases
• Schizophrenia
When sera of schizophrenic patients 
are tested with antibodies to HERVs, a 
greater frequency of positives is found 
than control subjects. Researchers 
continue to look at a possible link 
between HERVs and schizophrenia. 
Karlsson et al.7 have provided intriguing 
data that implicate the possibility of 
this link. The culprit that they implicate 
belongs to HERV-W. Indeed, they found 
that RNA transcripts homologous 
to members of this family are up-
regulated to different levels in the frontal 
cortex obtained post-mortem from 
schizophrenic patients.
• Motor Neuron Disease
Here elevated expression of 
HERV-W env and gag genes have 
been detected and proposed in the 
pathogenesis.7  
• Multiple Sclerosis
HERV-W RNA has been detected 
in the circulating viral particles (called 
Multiple Sclerosis associated Retroviral 
element, MSRV), which for many years 
have been associated with the evolution 
and prognosis of Multiple Sclerosis. 
Specifically, HERV-W env gene 
codes for an envelope protein called 
syncytin-1.8 Here syncytin, unlike its 
beneficial function in the morphogenesis 
of the placenta, acts as a powerful 
immuno-pathogeneic molecule that 
triggers a pro-inflammatory and 
autoimmune cascade.
(iv) Other Medical Diseases Where TEs 
Are Proposed To Be Involved
Table 15 gives other examples of 
medical diseases were retroelements 
cause insertional mutagenesis and re-
combinations in specific genes.
Repercussions
A very promising transposable 
element that is being used by 
researches worldwide is the Sleeping 
Beauty (SB) TE. This is an ancient 
transposon from fish which has been 
reconstructed. Its usefulness is three-
fold. Firstly, it is being used to gain 
knowledge into the basic molecular 
machinery of DNA transposition 
and its regulation in vertebrate cells. 
Secondly it is being used as a vector 
for insertional mutagenesis screens 
in model organisms; this is because 
SB can transpose in cells of different 
vertebrate classes in tissue culture. 
Such screens help in the discovery 
of genes. Thirdly, it is intended to be 
applied in human therapeutics.9  
In the field of medical therapeutics, 
understanding the underlying 
processes of how these relic HERVs 
and other transposons bring about 
human diseases could help in their 
prevention and treatment. Just to 
give an example, in multiple sclerosis 
a new therapeutic approach is 
to target the human endogenous 
retroviral protein MSRV-Env, which 
as said above has been found to be 
a key factor in the pathogenesis of 
MS.10   A fully humanized monoclonal 
antibody is being proposed to target 
this pathogenic protein. But this is not 
all. Indeed, MSRV could be used as 
a biomarker for the prognosis of the 
disease since patients with higher loads 
of MSRV fair worse. Similar approaches 
could also be used for the other medical 
diseases mentioned in this essay.
Autoimmune Disease
Rheumatoid arthritis HERV-K
Systemic lupus erythematosus HERV-K
Insulin Dependent diabetes mellitus HERV-K
Psoriasis HERV-E
Table 13: Putative association of HERVs in autoimmune diseases
Neurological Disease
Schizophrenia HERV-W, HERV-K
Motor neuron disease HERV-W
Multiple sclerosis HERV-W, HERV-H
Table 14: Putative association of HERVs in neurological diseases
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Retroelement 
Involved Gene Affected functional Role
LINE-1 Factor VIII Haemophilia A
LINE-1 Dystrophin Muscular dystrophy
SINE Fukutrin Muscular dystrophy
Alu NF1 Neurofibromatosis
HERVs
AZFa (azoospermia 
factor a) region
Male infertility
Table 15: Cases of insertional mutagenesis
 and re-combinations caused by retroelements
DNMTs inhibitors
• 5-azacytidine
• decitabine
DNA methyltransferase 
inhibitors
act as DNA 
demethylating agents 
and so reduce 
the levels of DNA 
methylation
HDAC inhibitors
• vorinostat
• valproic acid
Histone deacetylase 
(HDAC) inhibitors
acetyl groups are not 
removed from histone 
tails
Table 16: The four epigenetic drugs approved for clinical use in the US
Important strides are being made in 
the cancer field. For example HERVs 
transcriptomes (i.e.HERVs signatures) 
associated with specific types of cancer 
are being deciphered and databased.  
These are intended to be used in the 
future as a means for assessing (i) an 
individual’s risk status for cancer, (ii) 
the early detection of cancer and (iii) 
the monitoring of its treatment and 
prognosis. These signatures taken 
together with epigenetic signatures 
(e.g. DNA methylomes and histone 
codes) are very promising candidates 
as bio-indicators for the early detection 
of carcinogenesis. Again similar goals 
could also become applicable to other 
medical diseases where HERVs and 
epimutation signatures are found.
If as is being found HERVs and 
epimutation signatures cross talk in 
the pathogenesis of medical diseases, 
then as has been the case in some 
cancer types, epigenetic-based 
treatment strategies would become 
rational also. Already the FDA has 
approved the first generation of 
epigenetic-based drugs. Indeed, the 
use of such drugs is establishing that 
epigenetic modulation can be a 
feasible treatment option, not only for 
cancer, but also for the growing list of 
diseases where epigenetic mechanisms 
of gene expression underline their 
pathogenesis.11 And since epigenetic 
changes are thought to be responsible 
for a wide range of diseases, the 
scope of epigenetic therapy is likely to 
expand.12  
The four epigenetic drugs available 
for clinical use in the U.S. include 
two DNA demethylating agents, 
5-azacytidine and decitabine, and two 
histone deacetylase (HDAC) inhibitors, 
vorinostat and valproic acid.
At present the targets for epigenetic 
drugs are DNMTs and HDACs, the 
latter generating the most excitement. 
It is worth mentioning that since many 
other molecules are also involved in 
epigenetic mechanisms, there are 
other potential targets as well.  Similar 
‘bullet-targeting’ of other molecular 
players involved in HERVs-associated 
pathological pathways will surely be 
found and used in medical therapeutics.
Conclusion
For some HERV loci it has already 
been shown that they are implicated 
in certain gene expression and 
diseases. Large scale studies of HERV 
transcriptomes should be carried out to 
detail in the expression of more active 
HERV loci. This should be done in every 
human tissue both in health and in 
disease. Doing so one could then start 
to comprehend more the functions of 
HERVs in human diseases.
It is becoming clearly evident 
that an old relation in our genome is 
gaining new perspectives. But if the 
accumulating evidence definitely shows 
that this old relation is implicated in 
many of our medical diseases, then 
one could also surmise that these 
medical diseases that afflict us could 
be the prize that we have to pay for our 
marvellous evolution.  
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